Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Approved-not yet active				18 and over				Other				tasmc-05-na-05160-ctil NCT00295035


2.		Curcumin for Prevention of Oral Mucositis in Children Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				5 to 30				Other				Curcumin-HMO-CTIL NCT00475683


3.		Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				TASMC-07-NA-132-CTIL NCT00486460


4.		Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				8 to 65				Other				381 NCT00689195


5.		Curcumin for the Chemoprevention of Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Active				Over 18				Other				802193 NCT00118989


6.		Gemcitabine With Curcumin for Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				RonCurcuminPancreas.CTIL NCT00192842

Last Modified: 10/15/2007 First Published: 8/13/2006


7.		Phase II Chemoprevention Study of Curcumin in Current Smokers With Aberrant Crypt Foci

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Active				40 and over				NCI				UCIRVINE-UCI04-2-01 UCIRVINE-2005-4586, UIC-2005-0617, CCUM-HUM00000731, UCI04-2-01, NCT00365209


8.		Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 85				Other				00011821 NCT00641147


9.		Curcumin With Pre-Operative Capecitabine and Radiation Therapy Followed by Surgery for Rectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				2006-0644 NCT00745134

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute